Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Inventory Average (2016 - 2025)

Vanda Pharmaceuticals' Inventory Average history spans 14 years, with the latest figure at $10.5 million for Q4 2025.

  • On a quarterly basis, Inventory Average rose 530.51% to $10.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.5 million, a 530.51% increase, with the full-year FY2025 number at $6.4 million, up 6.83% from a year prior.
  • Inventory Average hit $10.5 million in Q4 2025 for Vanda Pharmaceuticals, up from $6.1 million in the prior quarter.
  • Over the last five years, Inventory Average for VNDA hit a ceiling of $10.5 million in Q4 2025 and a floor of $963500.0 in Q4 2021.
  • Historically, Inventory Average has averaged $4.5 million across 5 years, with a median of $5.5 million in 2022.
  • Biggest five-year swings in Inventory Average: surged 578.78% in 2022 and later tumbled 81.86% in 2025.
  • Tracing VNDA's Inventory Average over 5 years: stood at $963500.0 in 2021, then surged by 578.78% to $6.5 million in 2022, then dropped by 14.29% to $5.6 million in 2023, then crashed by 70.21% to $1.7 million in 2024, then soared by 530.51% to $10.5 million in 2025.
  • Business Quant data shows Inventory Average for VNDA at $10.5 million in Q4 2025, $6.1 million in Q3 2025, and $2.0 million in Q2 2025.